AWM
CBAY

Activest Wealth Management’s Cymabay Therapeutics CBAY Stock Holding History

Activest Wealth Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-69
Closed -$1.94K – 414
2023
Q4 		$1.63K Hold
69
– – ﹤0.01% 276
2023
Q3 		$1.03K Hold
69
– – ﹤0.01% 297
2023
Q2 		$927 Hold
69
– – ﹤0.01% 274
2023
Q1 		$620 Hold
69
– – ﹤0.01% 296
2022
Q4 		$433 Hold
69
– – ﹤0.01% 436
2022
Q3 		$0 Hold
69
– – ﹤0.01% 631
2022
Q2 		$0 Hold
69
– – ﹤0.01% 405
2022
Q1 		$0 Hold
69
– – ﹤0.01% 389
2021
Q4 		$0 Hold
69
– – ﹤0.01% 426
2021
Q3 		$1K Hold
69
– – ﹤0.01% 381
2021
Q2 		$1K Hold
69
– – ﹤0.01% 334
2021
Q1 		$1K Buy
+69
New +$371 ﹤0.01% 301

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Activest Wealth Management's CBAY Position: Q1 2024 in Review

Activest Wealth Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 69 shares — an estimated $1.94K sold.

Activest Wealth Management first reported a position in CBAY in Q1 2021 and held it in 12 quarters. The position peaked at $1.63K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Activest Wealth Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Activest Wealth Management sold 69 Cymabay Therapeutics shares in Q1 2024, an estimated $1.94K.
  • Activest Wealth Management first reported a position in Cymabay Therapeutics in Q1 2021 and held it in 12 quarters.
  • Activest Wealth Management's Cymabay Therapeutics position peaked at $1.63K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Activest Wealth Management's 13F filing for Q1 2024, filed 24 Apr 2024.